NO protection is crucial against angiotensin II (ANG II) mediated vasoconstriction in postnatal preglomerular resistance vessels. Although whole kidney NOS is developmentally regulated, NOS regulation ...
Okusa MD : A2A adenosine receptor: a novel therapeutic target in renal disease Am J Physiol Renal Physiol 2002; 282: F10–F18.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback